PERNIX THERAPEUTICS HLDGS IN

Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PERNIX THERAPEUTICS HLDGS IN DBCV 4.250 4/0, CUSIP 71426VAK4.